BIO CEO & Investor Conference 2005

** Please Click on the Name of each Focus Session/Company to View the Webcast **
February 23, 2005     February 24, 2005
 
Webcast Help Link
Thursday, February 24, 2005 (All times in EST)

Please Note: Some companies have chosen not to webcast

 
*Please note that there will be a 24 hour delay on Focus Session webcasts.
Focus Sessions   9:30 - 10:55am Location
Changing the Rules: The Impact of Emerging SEC Regulations Jade
Strategies for Building a Commercial Pipeline Astor Salon
Starving Cancer East Foyer
Diabetes: An Epidemic Growing Younger Basildon
Advances in Sexual Dysfunction and Genitourinary disorders Louis XVI
New Antibiotics Against New and Old Threats Duke of Windsor
Biotech and Eye disorders: Seeing Beyond the Obvious Conrad Suite
Strategies for Monoclonal Antibody Therapies Park Ave Suite Center/North
 
Company Presentations Date Time Location
Array BioPharma Inc. 2/24/2005 11:00 AM      Jade
Arena Pharmaceuticals, Inc. 2/24/2005 11:00 AM      Louis XVI
AtheroGenics, Inc. 2/24/2005 11:00 AM      Conrad Suite
AVANIR Pharmaceuticals, Inc. 2/24/2005 11:00 AM      East Foyer
La Jolla Pharmaceutical Company 2/24/2005 11:00 AM      Duke of Windsor
Maxygen, Inc. 2/24/2005 11:00 AM      Basildon
PTC Therapeutics, Inc. 2/24/2005 11:00 AM      Park Ave Suite Center/North
NPS Pharmaceuticals, Inc. 2/24/2005 11:00 AM      Astor Salon
Bavarian Nordic A/S 2/24/2005 11:30 AM      East Foyer
Corixa Corporation 2/24/2005 11:30 AM      Louis XVI
ImClone Systems Incorporated 2/24/2005 11:30 AM      Jade
NitroMed Inc. 2/24/2005 11:30 AM      Astor Salon
Saegis Pharmaceuticals, Inc. 2/24/2005 11:30 AM      Park Ave Suite Center/North
YM BioSciences Inc. 2/24/2005 11:30 AM      Duke of Windsor
NeoRx Corporation 2/24/2005 11:30 AM      Conrad Suite
Seattle Genetics, Inc. 2/24/2005 11:30 AM      Basilidon
Cubist Pharmaceuticals 2/24/2005 12:00 PM      Astor Salon
DOV Pharmaceutical, Inc. 2/24/2005 12:00 PM      East Foyer
GlycoGenesys, Inc. 2/24/2005 12:00 PM      Conrad Suite
Hawaii Biotech, Inc. 2/24/2005 12:00 PM      Park Ave Suite Center/North
Hollis-Eden Pharmaceuticals, Inc. 2/24/2005 12:00 PM      Louis XVI
MGI Pharma, Inc. 2/24/2005 12:00 PM      Jade
Rigel Pharmaceuticals, Inc. 2/24/2005 12:00 PM      Basildon
Cyberkinetics Neurotechnology Systems 2/24/2005 12:00 PM      Duke of Windsor
deCODE genetics, Inc. 2/24/2005 2:00 PM      Basildon
Emisphere Technologies, Inc. 2/24/2005 2:00 PM      Conrad Suite
Momenta Pharmaceuticals, Inc. 2/24/2005 2:00 PM      Louis XVI
Nuvelo, Inc. 2/24/2005 2:00 PM      East Foyer
Vicuron Pharmaceuticals Inc. 2/24/2005 2:00 PM      Jade
VIVUS, Inc. 2/24/2005 2:00 PM      Duke of Windsor
Encysive Pharmaceuticals Inc. 2/24/2005 2:00 PM      Astor Salon
Immusol, Inc. 2/24/2005 2:00 PM      Park Ave Suite Center/North
ACADIA Pharmaceuticals Inc. 2/24/2005 2:30 PM      Duke of Windsor
Biorexis Pharmaceutical Corporation 2/24/2005 2:30 PM      Park Ave Suite Center/North
GPC Biotech AG 2/24/2005 2:30 PM      Astor Salon
Theravance, Inc. 2/24/2005 2:30 PM      Jade
Keryx Biopharmaceuticals, Inc. 2/24/2005 2:30 PM      East Foyer
CoTherix 2/24/2005 2:30 PM      Basildon
ArQule, Inc. 2/24/2005 2:30 PM      Louis XVI
Therion Biologics Corporation 2/24/2005 2:30 PM      Conrad Suite
Elixir Pharmaceuticals, Inc. 2/24/2005 3:00 PM      Park Ave Suite Center/North
EPIX Pharmaceuticals, Inc. 2/24/2005 3:00 PM      East Foyer
MediGene AG 2/24/2005 3:00 PM      Basildon
RegeneRx Biopharmaceuticals, Inc. 2/24/2005 3:00 PM      Louis XVI
Spectrum Pharmaceuticals, Inc. 2/24/2005 3:00 PM      Duke of Windsor
Abgenix, Inc. 2/24/2005 3:00 PM      Jade
VaxGen, Inc. 2/24/2005 3:00 PM      Astor Salon
GlycoFi, Inc. 2/24/2005 3:00 PM      Conrad Suite
Biomira Inc. 2/24/2005 3:30 PM      Louis XVI
Genmab A/S 2/24/2005 3:30 PM      Basildon
Sirna Therapeutics, Inc. 2/24/2005 3:30 PM      East Foyer
PharmAthene, Inc. 2/24/2005 3:30 PM      Astor Salon
MacroPore Biosurgery 2/24/2005 3:30 PM      Conrad Suite
XDx Inc. 2/24/2005 3:30 PM      Park Ave Suite Center/North
Medarex, Inc. 2/24/2005 3:30 PM      Jade
Hybridon Inc. 2/24/2005 3:30 PM      Duke of Windsor
 
Focus Sessions   4:00 - 5:25pm Location
Evolution of a Biotech Company's Corporate Leadership Team Jade
Dealing with FDA Regulatory Designations Astor Salon
Zeroing in on the cure for cancer with exciting approaches East Foyer
Advances in Obesity Drugs Basildon
New inroads to treating Gastrointestinal disorders Louis XVI
Breathtaking new respitory drugs for COPD, Asthma and Allergies Duke of Windsor
Orphan drugs: Gaining Broader Adoption? Conrad Suite